Oncology

Filter

Chlormethine Gel Reshapes the Tumour Microenvironment in Mycosis Fungoides

9 Mins

March 2026

Cutaneous T cell lymphomas (CTCL) are a heterogenous group of rare malignancies primarily involving the skin, of which mycosis fungoides…

Advances in 2L ER+/HER2− mBC therapy

Despite advances in first-line endocrine therapy (ET) plus cyclin-dependent 4/6 kinase inhibitors (CDK4/6i) in oestrogen receptor-positive…

Inside the Cancer Vaccine Revolution: Interview with Lennard Lee

I’m a clinical academic, which is quite a rare breed of doctor, because what I’m doing, along with other clinical academics, is being…

Endometrial Cancer Research in 2024

Endometrial cancer is one of the most common gynaecological cancers in high-income countries and, for many years, has been associated…

31 Oct 2024

Tackling Infectious Diseases

This interactive article summarises key discussions from GSK sponsored symposia that took place during the ESCMID Global Congress 2024, held from 27–30th April 2024 in Barcelona, Spain.

ER+/HER2- Metastatic Breast Cancer – Treatment after ET + CDK4/6i

Over 70% of breast cancers are ER+/HER2-, for which the backbone of treatment is ET.1-3 Advanced breast cancer (aBC) can be considered to…

Patient-Centred Therapies for mNSCLC

The metastatic non-small cell lung cancer (mNSCLC) treatment landscape has vastly expanded over the past two decades as a result of…

Synergy of Tumour and Liquid Biopsy

The symposium took place during the 2024 European Society for Medical Oncology (ESMO) Congress in Barcelona, Spain, with the goal of…

Therapeutic Advances in Gastrointestinal Cancers: Immuno-oncology and Beyond

At the European Society for Medical Oncology (ESMO) Congress 2024 in Barcelona, Spain, the latest advancements in immunotherapy for…

Loading posts...

« Previous 1 2 3 4 5 6 … 31 Next »